The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis

Clinical Infectious Diseases

Volumn 33, Issue 11, 2001, Pages 1824-1833

  Perfect, J R ^a   Cox, G M ^a   Lee, J Y ^b   Kauffman, C A ^c   De Repentigny, L ^d   Chapman, S W ^e   Morrison, V A ^f   Pappas, P ^b   Hiemenz, J W ^g   Stevens, D A ^h  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c STRATTON VA MEDICAL CENTER   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e University of Mississippi Medical Center   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g ALBANY MEDICAL CENTER   (United States)

^h SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; BONE MARROW TRANSPLANTATION; BRONCHOPULMONARY ASPERGILLOMA; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NEUTROPENIA; PRIORITY JOURNAL; SPECIES DIFFERENTIATION;

ASPERGILLOSIS; ASPERGILLUS; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RISK FACTORS;

EID: 0035577380     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323900     Document Type: Article

References (82)

1. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: Lack of correlation
2. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
3. Correlation between in-vitro susceptibility testing to itraconazole and in vivo outcome of Aspergillus fumigatus infection
4. Aspergillus fumigatus and aspergillosis
5. Pulmonary aspergillosis during hospital renovation
6. Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms
7. Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infection
8. Restriction endonuclease analysis of total cellular DNA of Aspergillus isolates of geographically and epidemiologically diverse origin
9. Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction
10. Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit
11. 10-Year review of invasive aspergillosis detected at necropsy
12. Epidemiology of invasive aspergillosis in European cancer centers
13. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
14. Analysis of compassionate use of itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria
15. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive aspergillosis
16. Chronic invasive aspergillosis in apparently immunocompetent hosts
17. Semiinvasive pulmonary aspergillosis: CT and pathologic findings in six patients
18. Pulmonary aspergillomas: Diagnostic and therapeutic considerations
19. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis
20. Aspergillus: An increasing problem in tertiary care hospitals
21. Burden of aspergillosis-related hospitalizations in the United States
22. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy
23. Outbreak of systemic aspergillosis in a neonatal intensive care unit
24. Invasive pulmonary aspergillosis in a critically ill neonate: Case report and review of invasive aspergillosis during the first 3 months of life
25. In vitro amphotericln B resistance in clinical isolates of Aspergillus terreus with head-to-head comparison to voriconazole
26. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature
27. Aspergillus fungemia: Report of 2 cases and review
28. Significance of aspergillemia in patients with cancer: A 10-year study
29. Aspergillus valve endocarditis in patients without prior cardiac surgery
30. Central nervous system aspergillosis in patients with human immunodeficiency virus infection: Report of 6 cases and review
31. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction
32. Invasive pulmonary aspergillosis diagnosed early by polymerase chain reaction assay
33. Molecular epidemiological study of Aspergillus fumigatus in a bone marrow transplantation unit by PCR amplification of ribosomal intergenic spacer sequences
34. Hospital epidemiologic surveillance for invasive aspergillosis: Patient demographics and the utility of antigen detection
35. Detection of antigen in sera of patients with invasive aspergillosis: Intra- and inter-laboratory reproducibility
36. Invasive pulmonary aspergillosis: Prediction at thin-section CT in patients with neutropenia - A prospective study
37. Invasive aspergillosis of the airways: Radiographic, CT and pathologic findings
38. Aspergilloma: A series of 89 surgical cases
39. Allergic bronchopulmonary mycosis complicating cystic fibrosis
40. Allergic bronchopulmonary aspergillosis: Natural history and classification of early disease by serologic and roentgenographic studies
41. Chronic fungal sinusitis in apparently normal hosts
42. Aspergillosis: The spectrum of the disease in 98 patients
43. Invasive aspergillosis: Progress in early diagnosis and treatment
44. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: A 9-year study
45. Invasive aspergillosis in neutropenic patients with hematologic disorders
46. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis
47. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis
48. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
49. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis
50. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
51. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants
52. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
53. Stage-specific manifestation of mold infections in bone marrow transplant recipients: Risk factor and clinical significance of positive concentrated smears
54. Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease
55. Changing role of invasive aspergillosis in AIDS: A case control study
56. Pulmonary aspergillosis and invasive disease in AIDS: Review of 342 cases
57. Invasive aspergillosis in transplant recipients
58. Invasive aspergillosis in liver transplant recipients in the 1990s
59. Incidence and significance of Aspergillus cultures following liver and kidney transplantation
60. Infections in solid-organ transplant recipients
61. Molecular epidemiological study of invasive pulmonary aspergillosis in a renal transplantation unit
62. Invasive aspergillosis in renal transplant recipients: Correlation with corticosteroid therapy
63. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease
64. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation
65. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients
66. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
67. Aspergillus infection in single and double lung transplant recipients
68. Ulcerative tracheobronchitis after lung transplantation: A new form of invasive aspergillosis
69. Aspergillus airway colonization and invasive disease after lung transplantation
70. Invasive aspergillosis in systemic lupus erythematosus
71. Antifungal and surgical treatment of invasive aspergillosis: Review of 2,121 published cases
72. Practice guidelines for diseases caused by Aspergillus
73. Treatment strategies for Aspergillus infections
74. Invasive aspergillosis: Disease spectrum, treatment practices, and outcomes
75. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
76. Invasive aspergillosis in liver transplant recipients: Comparison of outcome with amphotericin B lipid complex and conventional amphotericin B therapy
77. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
78. An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis
79. An EORTC multicenter prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome
80. The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis
81. Amphotericin B with and without itraconazole for invasive aspergillosis: A three-year retrospective study
82. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis